Semantic Scholar uses AI to extract papers important to this topic.
Filibuvir, a non-nucleoside NS5B polymerase inhibitor for the potential oral treatment of chronic HCV infection.
- IDrugs : the investigational drugs journal
Filibuvir (PF-868554), being developed by Pfizer, is an orally administered, non-nucleoside inhibitor of the HCV NS5B RNA… (More)
Is this relevant?